Insulin and leptin concentrations in obese humans during long-term weight loss

Neth J Med. 1997 Sep;51(3):96-102. doi: 10.1016/s0300-2977(97)00051-x.

Abstract

Background: Leptin is likely to be involved in the homeostasis of body weight. Insulin is suggested to regulate both short-term and long-term circulating leptin levels. The present study aims to assess the relation between insulin and leptin levels in obese humans.

Methods: Some 53 obese subjects (body mass index 35.1 +/- 3.9 kg m-2 (mean +/- SD)) were prescribed a hypocaloric diet and randomized to either a placebo or the intestinal lipase inhibitor orlistat for 2 years. Serum leptin and insulin levels were determined repeatedly during these 2 years (5 times in the fasting condition and twice after an oral glucose load).

Results: Leptin concentrations appeared to be regulated at a specific level for each individual throughout the weight-loss period. The BMI explained 39.7% of the total variance in leptin levels, the body-fat distribution 17.2%, individual characteristics 30.3%; and the fasting serum insulin concentration 1.0%. After a mean weight loss of 7.7 +/- 4.9 kg, the time-integrated insulin response to an oral glucose load was significantly lower but the leptin response remained unchanged.

Conclusions: The BMI is the main determinant of the circulating leptin concentration in obese humans. Individual characteristics seem to determine the leptin level, given the BMI. In a short-term observational study in obese humans, changes of insulin levels do not appear to be correlated to changes in leptin levels.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Body Mass Index
  • Diet
  • Double-Blind Method
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Insulin / blood*
  • Lactones / therapeutic use
  • Leptin
  • Lipase / antagonists & inhibitors
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / diet therapy
  • Obesity / drug therapy*
  • Orlistat
  • Proteins / metabolism*
  • Single-Blind Method
  • Weight Loss / physiology*

Substances

  • Biomarkers
  • Enzyme Inhibitors
  • Insulin
  • Lactones
  • Leptin
  • Proteins
  • Orlistat
  • Lipase